Sign In
Buy CAH
$201.74
+5.89 (+3.01%)
At Close: Jun 04, 2026
For Cardinal Health, the Proof Will be in Its Performance
07:19am, Friday, 03'rd May 2024
Investors are familiar with the phrase "buy the rumor, sell the news." However, Cardinal Health Inc. NYSE: CAH proved that investors can buy and sell the news.
5 Expected Dividend Increases In May 2024
01:38am, Friday, 03'rd May 2024
5 Expected Dividend Increases In May 2024
Compared to Estimates, Cardinal (CAH) Q3 Earnings: A Look at Key Metrics
01:01pm, Thursday, 02'nd May 2024
The headline numbers for Cardinal (CAH) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimate
Cardinal Health, Inc. (CAH) Q3 2024 Earnings Call Transcript
12:17pm, Thursday, 02'nd May 2024
Cardinal Health, Inc. (NYSE:CAH ) Q3 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Matt Sims - VP, IR Jason Hollar - CEO Aaron Alt - CFO Conference Call Participants Lisa G
Cardinal Health (CAH) Beats on Q3 Earnings, Ups '24 EPS View
11:05am, Thursday, 02'nd May 2024
Cardinal Health's (CAH) third-quarter fiscal 2024 results benefit from solid profit growth in Pharmaceutical and Specialty Solutions. The company raises its EPS guidance for fiscal 2024.
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
08:52am, Thursday, 02'nd May 2024
Cardinal Health raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer.
Cardinal Health's stock falls on mixed quarterly results
07:08am, Thursday, 02'nd May 2024
Cardinal Health Inc.'s shares CAH, -0.84% fell 1.2% premarket on Thursday after the company reported mixed results for its fiscal third quarter but raised its full-year profit outlook. The drug distri
Cardinal Health Reports Third Quarter Fiscal Year 2024 Results and Raises Fiscal Year 2024 Non-GAAP EPS Guidance
06:45am, Thursday, 02'nd May 2024
Revenue increased 9% to $54.9 billion GAAP1 operating earnings were $367 million; GAAP diluted EPS was $1.05 Non-GAAP operating earnings increased 10% to $666 million; non-GAAP diluted EPS increased 2
Shhh! 3 Secret Retirement Stocks Flying Below Wall Street's Radar
03:12pm, Wednesday, 01'st May 2024
Investing for retirement can be one of the most essential steps to securing a future of overall financial stability. Nowadays, many investors need to start preparing a nest egg at a young age despite
What's in Store for Cardinal Health (CAH) in Q3 Earnings?
01:10pm, Monday, 29'th Apr 2024
Cardinal Health's (CAH) third-quarter fiscal 2024 results are expected to reflect solid performance in the Pharmaceutical and Specialty Solutions segment.
Seeking Clues to Cardinal (CAH) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:21am, Monday, 29'th Apr 2024
Besides Wall Street's top -and-bottom-line estimates for Cardinal (CAH), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qu
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
08:31am, Monday, 29'th Apr 2024
Apple, Cardinal Health Among 12 Companies To Announce Dividend Increases In First Half Of May
Here's What You Should Know About EBAY Ahead of Q1 Earnings
01:35pm, Friday, 26'th Apr 2024
EBAY's first-quarter 2024 performance will likely reflect strength across its advertising business amid softness in its active buyer base.
3 Medical Products Stocks Set to Beat This Earnings Season
12:31pm, Friday, 26'th Apr 2024
Here are three stocks, TXG, CAH and HOLX, which are expected to beat earnings estimates in the ongoing reporting cycle.
US FDA sends warning to Cardinal Health for marketing unapproved devices
01:15pm, Thursday, 25'th Apr 2024
The U.S. Food and Drug Administration on Thursday sent a warning letter to Cardinal Health after an inspection of its facility in Illinois showed that the company was marketing unapproved devices.
